Heme enhances electron transport chain activity and promotes the activation of the growth-promoting RAS-RAF-MEK signaling cascade. This results in a metabolic reprogramming that elevates the apoptotic threshold of the cells, thereby inhibiting venetoclax-induced MM cell death.